The former top executive at Blue Cross Blue Shield of Michigan saw a pay cut in his final year before retirement as the health insurance company experienced its biggest underwriting loss in at least a decade. Daniel Loepp, 67, who retired as Blue Cross' CEO on Dec. 31, received all-cash compensation of $13.9 million last year, or about $1.85 million less than 2023, the insurer announced Monday.
Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries of the health care and public opinion industries made a brave return to Midtown Manhattan. Just seven blocks over and five blocks up from where the shell casings hit the sidewalk, they gathered for gaiety in a glitzy ballroom. The occasion was the 2025 PRWeek Healthcare Awards, a celebration of the sector that crafts the public's perception of pharmaceutical companies, hospitals, health care insurers and care providers—through advertising, lobbying, corporate outreach, and so much more. Cocktail attire, please.
Florida insurance regulators have asked companies to hand over extensive amounts of data on people's pharmacy claims, including personal information and prescription drug usage, an unusual move for a state regulator that's raising privacy concerns. An eight-page request went out in recent weeks to pharmacy benefit managers seeking detailed information on pharmacy contracts, claims and payments. Pharmacy benefit managers operate the prescription drug benefits part of insurance plans.
HHS Secretary Robert F. Kennedy Jr. on Friday released a policy prohibiting public comments during his department's rulemaking process, ending more than 50 years of the public's involvement in crafting his department's rules. In the policy statement placed in the Federal Register, Kennedy's office argued that rescinding the policy goes back to the original intent of the Administrative Procedure Act.
The number of people enrolled in a private Medicare Advantage plan grew just 3.1% from 2024 to 2025 — well below projections from the federal government and Wall Street, and one of the slowest years of growth ever in the program.
Following complaints from constituents, a New York congressman is launching an examination of UnitedHealth Group's management of large physician groups in the state's Hudson Valley region. The inquiry by Congressman Patrick Ryan (D-N.Y.) seeks to gather information from community members about the quality and accessibility of healthcare services since UnitedHealth Group's Optum subsidiary purchased CareMount Medical and Crystal Run Healthcare in 2022 and 2023.